Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
9
|
Resverlogix Corp.
|
Aug 17, 2022 12:27AM
|
Re: Sneaking Suspicion...
|
9
|
Resverlogix Corp.
|
Feb 04, 2021 08:48PM
|
Re: Hope we have a good day today...
|
8
|
Resverlogix Corp.
|
Sep 21, 2020 06:57PM
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
8
|
Resverlogix Corp.
|
Aug 23, 2022 09:06AM
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
8
|
Resverlogix Corp.
|
Aug 04, 2020 05:00PM
|
Re: iceberg or ice cube?
|
8
|
Resverlogix Corp.
|
May 17, 2017 02:46PM
|
Re: Wow
|
8
|
Resverlogix Corp.
|
Dec 12, 2019 06:57AM
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
8
|
Resverlogix Corp.
|
Dec 05, 2019 07:03PM
|
Re: Dead money.
|
8
|
Resverlogix Corp.
|
Nov 20, 2020 04:01PM
|
Re: Another variation
|
8
|
Resverlogix Corp.
|
Mar 04, 2021 09:40AM
|
Re: Don's latest presentation
|
8
|
Resverlogix Corp.
|
Sep 22, 2020 08:02PM
|
Re: My guess is a second BTD is coming
|
8
|
Resverlogix Corp.
|
Feb 08, 2020 01:23PM
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
8
|
Resverlogix Corp.
|
Jan 18, 2022 08:33AM
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
8
|
Resverlogix Corp.
|
Mar 03, 2021 11:44AM
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
8
|
Resverlogix Corp.
|
Feb 12, 2021 03:52PM
|
Re: What pps would get you to cash out completely?
|
8
|
Resverlogix Corp.
|
Dec 03, 2020 03:45PM
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
7
|
Resverlogix Corp.
|
Jun 14, 2020 05:08PM
|
Cause for Delay
|
7
|
Resverlogix Corp.
|
Mar 16, 2017 10:45AM
|
Re: Merrill Lynch
|
7
|
Resverlogix Corp.
|
Jun 09, 2020 07:44PM
|
Re: New to Agoracom
|
7
|
Resverlogix Corp.
|
Dec 30, 2020 03:54PM
|